Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Atlanta Braves Holdings Series B
BATRK
$3.38B
| $493K | ﹤0.01% |
17,760
-9,056
| -34% | -$249K |
|
|
HEES
3252
DELISTED
H&E Equipment Services
HEES
| $491K | ﹤0.01% |
+19,547
| New | +$514K |
|
3253
Spectrum Brands
SPB
$2B
| $491K | ﹤0.01% |
8,963
-258,206
| -97% | -$13.8M |
|
3254
Xenon Pharmaceuticals
XENE
$5.89B
| $491K | ﹤0.01% |
48,286
-97,096
| -67% | -$823K |
|
|
RVNC
3255
DELISTED
Revance Therapeutics, Inc.
RVNC
| $491K | ﹤0.01% |
31,158
-360,391
| -92% | -$6.25M |
|
|
BMTC
3256
DELISTED
Bryn Mawr Bank Corp
BMTC
| $491K | ﹤0.01% |
+13,602
| New | +$515K |
|
3257
Carlisle Companies
CSL
$14.4B
| $489K | ﹤0.01% |
3,984
-1,631
| -29% | -$188K |
|
3258
Travelzoo
TZOO
$69M
| $488K | ﹤0.01% |
+36,429
| New | +$483K |
|
|
FNHC
3259
DELISTED
FedNat Holding Company Common Stock
FNHC
| $487K | ﹤0.01% |
30,362
+4,849
| +19% | +$88K |
|
3260
Gildan
GIL
$10.1B
| $486K | ﹤0.01% |
13,525
-540,382
| -98% | -$18.5M |
|
3261
PUT
LivaNova
LIVN
$4.31B
| $486K | ﹤0.01% |
5,000
| – | – |
|
3262
CALL
Transocean
RIG
$6.41B
| $485K | ﹤0.01% |
+55,700
| New | +$477K |
|
3263
Sunrun
RUN
$2.2B
| $484K | ﹤0.01% |
34,402
-2,911,923
| -99% | -$40.1M |
|
3264
Tucows
TCX
$104M
| $484K | ﹤0.01% |
+5,962
| New | +$434K |
|
|
VIVO
3265
DELISTED
Meridian Bioscience Inc
VIVO
| $484K | ﹤0.01% |
27,456
+2,626
| +11% | +$43.7K |
|
|
NEE.PRR
3266
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $484K | ﹤0.01% |
+7,818
| New | +$469K |
|
|
MSL
3267
DELISTED
Midsouth Bancorp, Inc.
MSL
| $483K | ﹤0.01% |
42,350
-10,523
| -20% | -$118K |
|
3268
NI Holdings
NODK
$316M
| $482K | ﹤0.01% |
30,110
-11,274
| -27% | -$174K |
|
3269
CALL
VanEck Oil Services ETF
OIH
$1.94B
| $482K | ﹤0.01% |
1,400
-4,405
| -76% | -$1.49M |
|
|
AXAS
3270
DELISTED
Abraxas Petroleum Corp
AXAS
| $482K | ﹤0.01% |
19,289
+2,536
| +15% | +$64.1K |
|
3271
Chunghwa Telecom
CHT
$33.3B
| $480K | ﹤0.01% |
+13,506
| New | +$470K |
|
3272
iShares S&P Small-Cap 600 Value ETF
IJS
$8.26B
| $480K | ﹤0.01% |
+6,500
| New | +$480K |
|
3273
WIX.com
WIX
$3.53B
| $478K | ﹤0.01% |
3,953
-143,579
| -97% | -$15.6M |
|
3274
Aurinia Pharmaceuticals
AUPH
$2.21B
| $477K | ﹤0.01% |
+73,424
| New | +$487K |
|
3275
Berkshire Hathaway Class B
BRK.B
$1.08T
| $477K | ﹤0.01% |
2,372
-609,812
| -100% | -$123M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.